Walking and Mediterranean diet may be the ticket to reducing dementia risk

The study explores the MedWalk intervention, promoting a Mediterranean-style diet and regular walking, to potentially slow cognitive decline in older adults without existing impairments. Despite COVID-19 disruptions, progress with 157 participants suggests this approach, rooted in psychosocial techniques, could offer a lifestyle-based deterrent against dementia and cognitive deterioration.

A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

June 20, 2024

Detailed data confirm benefits — and risks — of Eli Lilly’s Alzheimer’s drug

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval

July 17, 2023

Medicare’s Part D policy is blocking progress needed to achieve Black health equity

A new and effective class of anti-obesity medicines, along with lifestyle interventions and sometimes bariatric surgery, can help stem the rising tide of obesity in

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.